Alveda Pharmaceuticals Overview

  • Founded
  • 2006

Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Alveda Pharmaceuticals General Information

Description

Supplier of generic injectable pharmaceuticals and medical devices. The company supplies atropine sulphate, acetylcysteine, irinotecan, methylene blue, sterile water, piperacillin tazobactam, naloxone and epinephrine.

Contact Information

Website
www.alvedapharma.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Medical Supplies
Acquirer
Teligent
Primary Office
  • 40 Holy Street
  • Suite 801
  • Toronto, Ontario M4S 3C3
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alveda Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alveda Pharmaceuticals‘s full profile, request access.

Request a free trial

Alveda Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial